A Study of MORAb-009 in Patients With Solid Tumor

Clinical trial NCT01018784 · COMPLETED

Trial details

NCT number: NCT01018784
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Mesothelin-positive

Start date: 2009-11-01
Primary completion: 2012-05-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.